Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-18 5:00 pm Purchase | 2026-08-03 | 13G | PROCESSA PHARMACEUTICALS INC PCSA | Soleus Capital Master Fund L.P. | 160,943 5.800% | 160,943 (New Position) | Filing History |
| 2026-08-13 09:00 am Sale | 2026-06-30 | 13G | VERICEL CORPORATION VCEL | Soleus Capital Master Fund L.P. | 1,458,882 2.800% | -1,090,197 (-42.77%) | Filing History |
| 2026-08-13 09:00 am Sale | 2026-06-30 | 13G | CERUS CORP CERS | Soleus Capital Master Fund L.P. | 2,500,000 1.200% | -7,328,700 (-74.56%) | Filing History |
| 2026-08-13 09:00 am Purchase | 2026-06-30 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 1,843,504 9.900% | 875,396 (+90.42%) | Filing History |
| 2026-08-13 09:00 am Unchanged | 2026-06-30 | 13G | IMMUNIC INC IMUX | Soleus Capital Master Fund L.P. | 679,200 4.900% | 0 (Unchanged) | Filing History |
| 2026-08-13 09:00 am Purchase | 2026-06-30 | 13G | INSPIRE MED SYS INC INSP | Soleus Capital Master Fund L.P. | 1,931,436 6.700% | 460,688 (+31.32%) | Filing History |
| 2026-08-13 09:00 am Purchase | 2026-06-30 | 13G | PALISADE BIO INC COM P PALI | Soleus Capital Master Fund L.P. | 13,063,687 7.500% | 3,710,000 (+39.66%) | Filing History |
| 2026-06-18 5:00 pm Purchase | 2026-06-17 | 13G | BIODESIX INC BDSX | Soleus Capital Master Fund L.P. | 525,241 5.100% | 108,642 (+26.08%) | Filing History |
| 2026-05-27 5:00 pm Purchase | 2026-05-26 | 13G | PALISADE BIO INC COM P PALI | Soleus Capital Master Fund L.P. | 9,353,687 5.400% | 9,353,687 (New Position) | Filing History |
| 2026-05-27 5:00 pm Purchase | 2026-05-26 | 13G | INSPIRE MED SYS INC INSP | Soleus Capital Master Fund L.P. | 1,470,748 5.100% | 1,470,748 (New Position) | Filing History |
| 2026-05-08 5:01 pm Purchase | 2026-03-31 | 13G | NOVOCURE LTD NVCR | Soleus Capital Master Fund L.P. | 10,492,391 9.100% | 1,961,726 (+23.00%) | Filing History |
| 2026-05-08 5:01 pm Sale | 2026-03-31 | 13G | JASPER THERAPEUTICS INC NE JSPR | Soleus Capital Master Fund L.P. | 276,312 1.000% | -1,218,108 (-81.51%) | Filing History |
| 2026-05-08 5:01 pm Purchase | 2026-03-31 | 13G | GERON CORP GERN | Soleus Capital Master Fund L.P. | 41,508,659 6.500% | 8,500,000 (+25.75%) | Filing History |
| 2026-05-08 5:00 pm Purchase | 2026-03-31 | 13G | CONTEXT THERAPEUTICS INC CNTX | Soleus Capital Master Fund L.P. | 6,963,141 7.600% | 2,186,743 (+45.78%) | Filing History |
| 2026-05-08 5:00 pm Sale | 2026-03-31 | 13G | BIODESIX INC BDSX | Soleus Capital Master Fund L.P. | 416,599 4.100% | -83,401 (-16.68%) | Filing History |
| 2026-05-07 5:01 pm Purchase | 2026-05-06 | 13G | RIGEL PHARMACEUTICALS INC RIGL | Soleus Capital Master Fund L.P. | 968,108 5.200% | 309,963 (+47.10%) | Filing History |
| 2026-04-01 7:50 pm Purchase | 2026-03-31 | 13G | VERICEL CORPORATION VCEL | Soleus Capital Master Fund L.P. | 2,549,079 5.000% | 2,549,079 (New Position) | Filing History |
| 2026-03-24 4:45 pm Purchase | 2026-03-23 | 13G | CERUS CORP CERS | Soleus Capital Master Fund L.P. | 9,828,700 5.100% | 9,828,700 (New Position) | Filing History |
| 2026-03-09 5:00 pm Purchase | 2026-03-06 | 13G | PULMONX CORP LUNG | Soleus Capital Master Fund L.P. | 2,665,100 6.500% | 2,665,100 (New Position) | Filing History |
| 2026-03-03 4:30 pm Purchase | 2026-02-25 | 13G | GERON CORP GERN | Soleus Capital Master Fund L.P. | 33,008,659 5.200% | 33,008,659 (New Position) | Filing History |